ZUG, Switzerland and CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following virtual investor conferences in March:

Read more here:
CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh